REFERENCES
- S.H. Park, E.K. Park, and D.H. Kim. 2005. Passive cutaneous anaphylaxis-inhibitory activity of flavanones from Citrus unshiu and Poncirus trifoliata. Planta Med. 71:24–27.
- M. Suzuki, K. Sasaki, F. Yoshizaki, K. Oguchi, M. Fujisawa, and J.C. Cyong. 2005. Anti-hepatitis C virus effect of citrus unshiu peel and its active ingredient nobiletin. Am. J. Chin. Med. 33:87–94.
- S.M. Jeong, S.Y. Kim, D.R. Kim, S.C. Jo, K.C. Nam, D.U. Ahn, and S.C. Lee. 2004. Effect of heat treatment on the antioxidant activity of extracts from citrus peels. J. Agric. Food Chem. 52:3389–3393.
- A. Murakami, Y. Nakamura, K. Torikai, T. Tanaka, T. Koshiba, K. Koshimizu, S. Kuwahara, Y. Takahashi, K. Ogawa, M. Yano, H. Tokuda, H. Nishino, Y. Mimaki, Y. Sashida, S. Kitanaka, and H. Ohigashi. 2000. Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation, oxidative stress, and tumor promotion in mice. Cancer Res. 60:5059–5066.
- D.K. Kim, K.T. Lee, J.S. Eun, O.P. Zee, J.P. Lim, S.S. Eum, S.H. Kim, and T.Y. Shin. 1999. Anti-allergic components from the peels of Citrus unshiu. Arch. Pharm. Res. 22:642–645.
- K. Higashi-Okai, K. Kamimoto, A. Yoshioka, and Y. Okai. 2002. Potent suppressive activity of fresh and dried peels from Satsuma mandarin Citrus unshiu (Marcorv.) on hydroperoxide generation from oxidized linoleic acid. Phytother. Res. 16:781–784.
- S. Ansorge, D. Reinhold, and U. Lendeckel. 2003. Propolis and some of its constituents own-regulate DNA synthesis and inflammatory cytokine production but induce TGF-beta 1 production of human immune cells. Z. Naturforsch. [C]. 58:580–589.
- E.M. Galati, M.T. Monforte, S. Kirjavainen, A.M. Forestieri, A. Trovato, and M.M. Tripodo. 1994. Biological effects of hesperidin, a citrus flavonoid (Note I): Antiinflammatory and analgesic activity. Farmaco 40:709–712.
- D.H. Kim, M.J. Song, E.A. Bae, and M.J. Han. 2000. Inhibitory effect of herbal medicines on rotavirus infectivity. Biol. Pharm. Bull. 23:356–358.
- G. Kaur, N. Tirkey, and K. Chopra. 2006. Beneficial effect of hesperidin on lipopolysaccharide-induced hepatotoxicity. Toxicology 226 (2–3):152–160.
- Long Zhixian. English-Chinese Collegiate Textbook in Traditional Chinese Medicine for Institution of Traditional Chinese Medicine of Higher Learning Edited by Beijing University of Traditional Chinese Medicine. Xue Yuan: Academy Press. 1998, 145.
- B.K. Tan; C.H. Tan; P.N. Pushparaj Life Sci. 2005, 76, 2827. Anti-diabetic activity of the semi-purified fractions of Averrhoa bilimbi in high fat diet fed-streptozotocin - induced diabetic rats.
- M. Mukai; K. Ozasa; K. Hayashi; K. Kawai Dig. Dis. Sci. 2002, 47, 549. Various S-GOT/S-GPT ratios in nonviral liver disorders and related physical conditions and life-style.
- J.L. Ble-Castillo; A. Rodriguez-Hernandez; R. Miranda-Zamora; M.A. Juarez-Oropeza; J.C. Diaz-Zagoya Life Sci. 2002, 70, 2665. Arthrospira maxima prevents the acute fatty liver induced by the administration of simvastatin, ethanol and a hypercholesterolemic diet to mice.
- J. Wojcicki, L. Samochowiec, M. Jaworska, and A. Hinek. 1985. A search for a model of experimental atherosclerosis: comparative studies in rabbits, guinea pigs and rats. Pol. J. Pharmacol. Pharm. 37 (1):11–21.
- F.M. Sacks, M.A. Pfeffer, L.A. Moye, J.L. Rouleau, J.D. Rutherford, T.G. Cole, and et al 1996. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N. Engl. J. Med. 335 (14):1001–9.
- T. Gordon, W.P. Castelli, M.C. Hjortland, W.B. Kannel, and T.R. Dawber. 1977. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am. J. Med. 62 (5):707–14.
- D.J. Gordon, and B.M. Rifkind. 1989. High-density lipoprotein—The clinical implications of recent studies. N. Engl. J. Med. 321 (19):1311–6.
- D. Reichl, and N.E. Miller. 1989. Pathophysiology of reverse cholesterol transport. Insights from inherited disorders of lipoprotein metabolism. Arteriosclerosis 9 (6):785–97.